What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down [Yahoo! Finance]
Ocular Therapeutix, Inc. (OCUL)
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ocutx.com
Company Research
Source: Yahoo! Finance
On February 17, 2026, VR Adviser, LLC disclosed in a U.S. Securities and Exchange Commission filing that it sold 5,845,915 shares of Ocular Therapeutix (NASDAQ:OCUL) , an estimated $71.01 million trade based on quarterly average pricing. VR Adviser, LLC Sold 5,845,915 shares of Ocular Therapeutix; estimated transaction value of $70.96 million based on quarterly average price. The quarter-end value of the position dropped by $65.05 million, reflecting both trading and Ocular Therapeutix share price changes. The transaction represented 3.51% of VR Adviser, LLC's reportable assets under management. Following the sale, VR Adviser, LLC held 7,315,547 shares ($88.81 million) Ocular Therapeutix now accounts for 4.39% of fund AUM, placing it outside the fund's top five holdings What happened According to a February 17, 2026, SEC filing , VR Adviser, LLC reduced its position in Ocular Therapeutix (NASDAQ:OCUL) by 5,845,915 shares during the fourth quarter. The estimated transact
Show less
Read more
Impact Snapshot
Event Time:
OCUL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCUL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCUL alerts
High impacting Ocular Therapeutix, Inc. news events
Weekly update
A roundup of the hottest topics
OCUL
News
- Is It Time To Reassess Ocular Therapeutix (OCUL) After Its Recent Share Price Slide [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Avoid OCUL and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL) [Yahoo! Finance]Yahoo! Finance
- Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Ocular Therapeutix, Inc. (OCUL) Discusses Phase III SOL-1 Data Highlighting Transformative Durability in Wet AMD Transcript [Seeking Alpha]Seeking Alpha
OCUL
Earnings
- 11/4/25 - Beat
OCUL
Sec Filings
- 2/27/26 - Form 8-K
- 2/25/26 - Form 4
- 2/25/26 - Form 4
- OCUL's page on the SEC website